Determination of shelf life and activation energy for tumor necrosis factor-alpha in cerebrospinal fluid samples

被引:0
|
作者
Ruiz, MC [1 ]
Quijano, FR [1 ]
Cortes, LFL [1 ]
Duvison, MH [1 ]
Rubio, RV [1 ]
机构
[1] HOSP UNIV VIRGEN DEL ROCIO, DEPT INTERNAL MED, INFECT DIS UNIT, SEVILLE, SPAIN
关键词
sample handling; accelerated stability testing; meningitis; pyogenic; cytokines; inflammation;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The cytokine tumor necrosis factor-alpha (TNF-alpha) plays a prominent role in the inflammatory response and has been quantified in several kinds of body fluids. A safe method for keeping samples under the best storage conditions for later studies is clearly needed. We estimated TNF-alpha shelf life by using an accelerated stability testing protocol based on the Arrhenius equation. We investigated two kinds of samples: cerebrospinal fluid (CSF) normal pool (from patients without meningitis) and CSF pathological pool (from patients mith pyogenic meningitis). Results of the stress protocol indicated that storing both normal and pathological CSF samples at -70 degrees C would maintain sample stability-i.e., retain at least 90% of the original TNF-alpha content-for similar to 5 years. At -20 degrees C and 4 degrees C, the projected stability time at which the same recovery would be obtained was 190 and 90 days, respectively.
引用
收藏
页码:670 / 674
页数:5
相关论文
共 50 条
  • [31] Recent progress in the tumor necrosis factor-alpha field
    Rink, L
    Kirchner, H
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (03) : 199 - 209
  • [32] Tumor necrosis factor-alpha promotor polymorphisms and endometriosis
    Wenzl, R
    Tempfer, C
    Schneeberger, C
    Zellinger, R
    Huber, J
    Wieser, F
    FERTILITY AND STERILITY, 2002, 78 (03) : S203 - S203
  • [33] GENE SEQUENCE OF FELINE TUMOR NECROSIS FACTOR-ALPHA
    MCGRAW, RA
    COFFEE, BW
    OTTO, CM
    DREWS, RT
    RAWLINGS, CA
    NUCLEIC ACIDS RESEARCH, 1990, 18 (18) : 5563 - 5563
  • [34] ELISA FOR QUANTITATION OF TUMOR NECROSIS FACTOR-ALPHA IN SERUM
    PRINCE, WS
    HARDER, KJ
    SAKS, S
    REED, BR
    CHEN, AB
    JONES, AJS
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1987, 5 (08) : 793 - 802
  • [35] Tumor necrosis factor-alpha induced enhancement of cryosurgery
    Goel, Raghav
    Paciotti, Guilio F.
    Bischof, John C.
    PHOTONIC THERAPEUTICS AND DIAGNOSTICS IV, 2008, 6842
  • [36] Serum tumor necrosis factor-alpha in neonatal sepsis
    Atici, A
    Satar, M
    Cetiner, S
    Yaman, A
    AMERICAN JOURNAL OF PERINATOLOGY, 1997, 14 (07) : 401 - 404
  • [37] Role of Tumor Necrosis Factor-Alpha in Rheumatoid Arthritis
    Link, Tina
    Kepner, Alisa
    Coruso, Olivia
    Dilip, Megha
    Jacobson, Reagan
    Stanovski, Lisa
    FASEB JOURNAL, 2018, 32 (01):
  • [38] Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha
    Cai, Weibo
    Kerner, Zachary J.
    Hong, Hao
    Sun, Jiangtao
    BIOCHEMISTRY INSIGHTS, 2008, 1 : 5 - 21
  • [39] Engineering a Synthetic Ligand for Tumor Necrosis Factor-Alpha
    Gupta, Nidhi
    Belcher, Paul E.
    Johnston, Stephen Albert
    Diehnelt, Chris W.
    BIOCONJUGATE CHEMISTRY, 2011, 22 (08) : 1473 - 1478
  • [40] Tumor necrosis factor-alpha and HERG K channel
    不详
    HEART RHYTHM, 2004, 1 (03) : 370 - 370